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Disturbances in circadian rhythm might play a central role in the neurobiology of depression. We examined the association
between depressive symptoms and 24-hour ambulatory BP in a sample of 405 (197 black and 208 Caucasian) urbanized African
teachers aged 25 to 60 yrs (mean 44.6 ± 9.6 yrs). Depressive symptoms were assessed using the self-administered 9-item Patient
Health Questionnaire (PHQ-9). After adjusting for age, sex, and ethnicity, participants with severe depressive symptoms (PHQ-9
≥ 15) had higher odds of hypertension deﬁned from ambulatory BP and/or use of antihypertensive medication (odds ratio = 2.19,
95% CI, 1.00–4.90) in comparison to participants with no symptoms. Compared to Caucasians with no depressive symptoms,
those with severe symptoms had blunted nocturnal systolic BP drop of 4.7mmHg (95% CI, −0.5 to 10.0, P = 0.07). In summary,
depressive symptoms were associated with the circadian BP proﬁle in black and Caucasian Africans.
1.Introduction
Studies examining the association between common mood
disorder, such as depression and risk of hypertension, have
produced mixed ﬁndings. Several studies have reported
positive associations between depression and risk of incident
hypertension [1–4] whereas others have observed null ﬁnd-
ings [5, 6], or attributed the eﬀects to hypertension labeling
[7]. There is even some evidence to suggest lower blood
pressure (BP) in participants with depressive symptoms [8,
9]. In the Whitehall II study of British civil servants that
examined longitudinal trajectories, the risk of hypertension
increased with repeated experience of depressive episodes
over time and became evident in later adulthood [10].
Thus, the association between depression and hypertension
is complex.
One limitation of this body of work is the reliance on
clinic BP readings taken on one occasion. In a recent study
of older participants that underwent 24-hour ambulatory
BPrecordings,thosereportingdepressivesymptomsdemon-
strated a blunted nocturnal systolic BP fall and were more
likely to be nondippers, deﬁned as having nocturnal systolic
BP fall of less than 10% [11]. There is increasing recognition
that disturbances in circadian rhythm play a central role
in the neurobiology of depression, even recognizing its
importance as a novel pharmacological target in treating
the disorder [12]. Depression is associated with alterations
in hormone and catecholamine circadian rhythms [13],
whichmaybetheresultofpoorlyregulatedneurotransmitter
feedback control systems that become erratic when chron-
ically stressed. Melatonin, for example, is an endogenous
antihypertensive molecule released by the pineal gland that2 International Journal of Hypertension
plays a role in the biological regulation of circadian rhythms
and has been associated with depression. In addition,
nocturnalmelatoninsecretionisimpairedamongnondipper
hypertensive patients [14].
Further studies are required to examine the association
between depressive symptoms and the circadian BP proﬁle,
which might help to further clarify the equivocal nature
of existing literature. The aim of this study was therefore
to examine the association between depressive symptoms
and circadian BP proﬁles using 24-hour ambulatory mon-
itoring. The study was conducted in a sample of black
and Caucasian Africans who were recruited as part of the
Sympathetic Activity and Ambulatory Blood Pressure in
Africans (SABPA) study—presently the only study in sub-
Saharan Africa focusing on the contribution of psychosocial
risk factors to cardiovascular health. Thus, a further aim
was to assess potential ethnic diﬀerences in the association
between depression and BP.
2. Methods
2.1. Participants and Procedures. Participants were recruited
as part of the SABPA study conducted between February
2008 and May 2009. The study sample comprised urbanized
African teachers working for the Dr. Kenneth Kaunda Edu-
cation district in the North West Province, South Africa. The
reason for this selection was to obtain a homogenous sample
from a similar socioeconomic class. All eligible participants
between the ages of 25 and 60 years were invited to partici-
pate.Exclusioncriteriawereanoraltemperatureabove37◦C,
psychotropic substance dependence or abuse, blood donors,
and individuals vaccinated in the past 3 months. Participants
w e r ef u l l yi n f o r m e da b o u tt h eo b j e c t i v e sa n dp r o c e d u r e so f
the study prior to their recruitment. Assistance was available
foranyparticipantwhorequestedconveyanceofinformation
in their home language. All participants signed an informed
consent form and the study was approved by The Ethics
Review Board of the North-West University (Potchefstroom
Campus). Participants were transported at 1630 hours to
the Metabolic Unit Research Facility of the North-West
University and familiarized with the protocol and completed
a battery of psychosocial questionnaires. After receiving a
standardized dinner participants were encouraged to go to
bed at around 2200 hours and were woken at 0545 hours
the following morning to undergo a battery of clinical
assessments.
2.2. Depressive Symptoms. Depressive symptoms were
assessed using the self-administered 9-item Patient Health
Questionnaire (PHQ-9), which has been extensively
validated in various clinical patient groups and diﬀerent
ethnic populations including sub-Saharan Africans [15, 16].
In the present study the PHQ-9 displayed good reliability
(Cronbach’s alpha = 0.81). The PHQ-9 measures the
frequency of depressive symptoms corresponding to the
9 key symptoms of depression used by the Diagnostic
and Statistical Manual of Mental Disorder Fourth Edition
(DSM-IV) criteria to diagnosed major depressive episode.
Participants indicated the frequency of experiencing
symptoms during the prior two weeks, ranging from
“not at all” (scored as zero), “several days” (one point),
“more than half the days” (two points), “nearly every day”
(three points), thus giving possible scores of 0–27. We
used previously described PHQ-9 cut points (15) to derive
three categories; no depressive symptoms (score <5), mild-
moderate symptoms (score of 5–14), and severe symptoms
(score of 15 and above).
2.3. Blood Pressure Measures. Semirecumbent clinic BP was
measured twice using a mercury Sphygmomanometer with a
5-minute rest between each reading. Participants underwent
24-h ambulatory BP monitoring during the working day
prior to the clinic visit. At ∼0800 hours, participants
were attached with an ambulatory BP monitor (Meditech
CE120 CardioTens; Meditech, Budapest, Hungary) on the
nondominant arm at their workplace. The apparatus was
programmed to measure BP at 30min intervals during the
day (0800–2200 hours) and every hour during nighttime
(2200–0600 hours). On average, the cuﬀ successfully inﬂated
72.6% of the time across all participants. Participants were
asked to continue with normal daily activities and record
any abnormalities such as headache, nausea, and feeling
stressed on their ambulatory diary cards. The data was
analyzed using the CardioVisions 1.15 Personal Edition
software (Meditech). Hypertension was deﬁned as mean 24-
hour BP >125/80mmHg [17], and nondippers were deﬁned
as participants having nocturnal systolic BP fall of less than
10% of their average daytime BP [18].
2.4. Covariates. Sodium ﬂuoride, plasma, and serum sam-
ples from fasting blood were stored at −80◦C for the
analysisofbiochemicalriskmarkers.Fastingsodiumﬂuoride
(glucose) and serum samples for total and high-density
lipoprotein (HDL) cholesterol, gamma glutamyl transferase,
and high-sensitivity C-reactive protein (CRP) were ana-
lyzed using two sequential multiple analyzers (Konelab 20i;
Thermo Scientiﬁc, Vantaa, Finland; Unicel DXC 800—
Beckman and Coulter, Germany). The intra- and intercoeﬃ-
cients of variation for all assays was below 10%.
2.5. Statistical Analyses. Diﬀerences in the characteristics
of participants in relation to depressive symptoms were
analysedusingANOVAteststoexaminecontinuousvariables
andchi-squareteststoexaminecategoricalvariables.AllCRP
values were log transformed to normalize the distribution.
GenerallinearmodelswereusedtoexaminediﬀerencesinBP
between depressive symptoms categories. Logistic regression
wasusedtoexaminetheassociationsofdepressivesymptoms
with hypertension and nondipper status. Hypertension was
deﬁned from BP readings and/or use of antihypertensive
medication.Themodelswereadjustedforcovariates,includ-
ing age, sex, ethnicity, CRP, body mass index, total/HDL
cholesterol, and glucose. These covariates were selected on
an ap r i o r ibasis, as depressive behavior is accompanied
by perturbations in glucose and lipid metabolism, inﬂam-
matory, and neural serotonergic system function, all ofInternational Journal of Hypertension 3
Table 1: Characteristics of the study sample (N = 405).
Variable No depressive symptoms Mild- moderate depressive symptoms Severe depressive symptoms
Black (n = 42) Caucasian
(n = 101) Black (n = 120) Caucasian
(n = 95) Black (n = 35) Caucasian
(n = 12)
Age (yrs) 43.8 ±7.34 6 .3 ±10.84 4 .7 ±8.34 3 .8 ± 10.74 3 .3 ±7.84 3 .3 ±11.3
Sex (% men) 66.7 58.4 58.8 45.7 34.3∗ 33.3∗
Body mass index (kg·m2)2 7 .7 ±6.62 7 .2 ±5.43 0 .7 ±7.22 7 .7 ±6.53 1 .2 ±7.1∗ 29.8 ±6.7
Total/HDL cholesterol ratio 4.41 ±1.85 5.21 ±1.63 4.34 ±1.58 4.71 ± 1.58 5.08 ±3.31 5.41 ±1.69
C-reactive protein (mg/L)† 3.95 (54.3) 1.10 (14.1) 5.05 (53.6) 1.90 (26.3) 5.33 (32.5) 2.90 (25.7)∗
Glucose (mmol/L) 5.59 ±2.23 5.80 ±0.97 5.59 ±1.64 5.55 ± 0.62 5.92 ±3.01 5.53 ±0.50
Antihypertensive medication
usage (%) 21.5 8.9 22.5 8.4 14.3 8.3
∗P<0.05 for trend across depressive symptom groups compared within own ethnicity; values displayed as mean ± SD unless stated (†non-normally
distributed values displayed as median and range).
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Figure 1: Association between depressive symptoms and mean 24-
hour ambulatory systolic blood pressure in black and Caucasian
Africans. White, grey, and black bars represent none, mild-
moderate, and severe depressive symptoms, respectively. Values
for blood pressure are mean ± SEM, adjusted for age, sex, and
antihypertensive medication.
which are associated with exacerbated hypertension [19]. We
ﬁtted interaction terms in order to assess potential ethnic
diﬀerences in the association between depression and BP. All
analyses were conducted using SPSS version 14.
3. Results
The sample comprised 197 black (aged 44.2 ± 8.0yrs)and
208 Caucasians (aged 45.0 ± 10.8yrs). Severe depressive
symptoms were reported in 11.6% of the sample. Black
participants were more likely to report any depressive
symptomscomparedwithCaucasians(age-andsex-adjusted
odds ratio = 3.72, 95%CI, 2.35–5.89). Depressivesymptoms
were associated with several risk factors including higher
body massindex andelevatedCRP (seeTable 1).Inaddition,
black ethnicity was strongly related to other risk factors,
including elevated CRP, BMI, and BP.
Hypertensionwasprevalentin62.1%ofthesamplewhen
usingthe24-hourambulatoryBPcriteria.Therewasastrong
Table 2: The association between depressive symptoms and hyper-
tension deﬁned from 24hr ambulatory blood pressure readings.
(N = 405).
Depressive
symptoms Cases/N Model 1 OR
(95% CI)
Model 2 OR
(95% CI)
None 80/143 Reference Reference
Mild-moderate 142/215 1.91 (1.15–3.18) 1.79 (1.02–3.13)
Severe 32/47 2.19 (1.00–4.90) 1.86 (0.76–4.57)
‡deﬁned as mean 24hr BP ≥ 125/80mmHg and/or use of antihypertensive
medication.
Model 1; adjustment for age, sex, ethnicity.
Model 2; adjustment for age, sex, ethnicity, + C-reactive protein, body mass
index, total/HDL cholesterol, glucose.
correlation between clinic and ambulatory systolic BP (r =
0.74, P<0.001). Black participants recorded higher 24-hour
systolic BP (age-, sex-, medication-adjusted β = 7.8, 95%
CI, 5.0–10.6mmHg) compared to Caucasians. There was
an association between depressive symptoms and 24-hour
ambulatory BP (see Figure 1). For example, compared to
participants with no depressive symptoms, those with severe
symptoms had marginally increased 24-hour systolic BP of
4.2mmHg (95% CI, −0.5 to 8.9, P = 0.08) after adjustment
for age, sex, ethnicity, and antihypertensive medication.
Depressive symptoms were associated with a twofold risk of
hypertension deﬁned from 24-hour ambulatory BP moni-
toring (Table 2), although when hypertension was deﬁned
from clinic BP readings (≥140/90mmHg) there was no
associations with depression (odds ratio of hypertension
for severe depressive symptoms = 1.36, 95% CI, 0.63–
2.96). The associations of depressive symptoms and 24-
hour hypertension were slightly attenuated after further
adjustments for other risk factors including body mass
index, CRP, total/HDL cholesterol, and glucose. We found
no evidence for any statistically signiﬁcant ethnic diﬀerences
in the association between depression and BP. The removal
of four participants who reported use of antidepressant
medication did not alter any of the results.
Fifty-nine participants (14.5%) recorded experiencing
stress on their diary cards during the ambulatory monitoring4 International Journal of Hypertension
Table 3: The association between depressive symptoms and
nondipper status.
Depressive
symptoms Cases/N Model 1 OR
(95% CI)
Model 2 OR
(95% CI)
None 45/143 Reference Reference
Mild-moderate 75/215 1.04 (0.65–1.67) 1.01 (0.62–1.63)
Severe 23/47 1.74 (0.85–3.58) 1.74 (0.83–3.63)
Model 1; adjustment for age, sex, ethnicity, antihypertensive medication.
Model 2; adjustment for age, sex, ethnicity, antihypertensive medication +
C-reactive protein, BMI, total/HDL cholesterol, glucose.
day, and those participants had elevated 24-hour systolic BP
compared with nonstressed (age-, sex-, ethnicity-adjusted
β = 5.5, 95% CI, 1.7 to 9.3mmHg, P = 0.004). Participants
reporting severe depressive symptoms were more likely to
report feeling stressed (age-, sex-, ethnicity-adjusted odds
ratio = 2.96, 95% CI, 1.16–7.50). When we added stress as
a covariate, the diﬀerence in 24-hour systolic BP between
participants reporting none and severe depressive symptoms
was no longer evident (β = 3.3, 95% CI, −1.4 to 8.0mmHg,
P = 0.16), which suggests stress might partly explain the link
between depression and the circadian BP proﬁle.
We further examined the association between depressive
symptoms and nocturnal BP decline (Table 3 and Figure 2).
A nocturnal systolic BP fall of less than 10% (nondipper)
was observed in 31.4% of the sample, and black participants
weremorelikelytobenondipperscomparedwithCaucasians
(age-, sex-, medication-adjusted odds ratio = 1.62, 95% CI,
1.04–2.51). There was a weak association between depressive
symptoms and nocturnal BP decline that was particularly
evident in Caucasians. For example, compared to Caucasians
with no depressive symptoms, those with severe symptoms
had blunted nocturnal systolic BP drop of 4.7mmHg (95%
CI, −0.5 to 10.0, P = 0.07) after adjustment for age, sex,
and antihypertensive medication (Figure 2). In the whole
sample there was evidence of elevated risk of nondipping in
participants with severe depressive symptoms although this
did not reach statistical signiﬁcance (Table 3), nor was there
any signiﬁcant interaction by ethnicity.
4. Discussion
This is presently the only study in sub-Saharan Africa to
examine the association between depressive symptoms and
risk of hypertension. Black Africans are known to have
elevated BP compared with Caucasians [20], and this was
conﬁrmed in the present study. Black participants from
the present study also demonstrated a higher prevalence of
depressive symptoms. Despite this, the association between
depressive symptoms and BP remained independent of
ethnicity and there wasno evidenceforanysigniﬁcant ethnic
diﬀerences in the association between depression and BP.
Previous studies in this area have been limited by only
taking clinic BP readings, but in the present study we also
collected data from 24-hour ambulatory BP monitoring.
Our main ﬁndings show an association between depressive
symptoms and 24-hour ambulatory BP. To our knowledge,
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Figure 2: Association between depressive symptoms and change
in ambulatory systolic blood pressure between daytime and night
in black and Caucasian Africans. White, grey, and black bars
represent none, mild-moderate, and severe depressive symptoms,
respectively. Values for blood pressure are mean ± SEM, adjusted
for age, sex, and antihypertensive medication.
only one other study examining depression has employed
ambulatory BP monitoring [11]. They found an association
betweendepressivesymptomsandbluntednocturnalsystolic
BP fall. Our ﬁndings are partly consistent with those results
although we did not ﬁnd strong evidence for an association
between depression and risk of nondipping, which might
be explained by the older age of participants from the
previous study. Several large epidemiological cohort studies
have found evidence for an association between depression
and elevated risk of incident hypertension at followup [1–
3, 10]. However, in other studies depressive disorder was
associated with lower systolic BP [8, 9], although use of
tricyclic antidepressants was associated with greater risk of
hypertension [5, 8]. These inconsistencies might therefore
be partially explained by inadequate assessments of BP,
antidepressant medication, diﬀerent measures of symptoms
and diagnostic criteria for depression, or other confounding
factors.
The associations between depressive symptoms and 24-
hour BP were attenuated after further adjustments for other
risk factors including body mass index, CRP, cholesterol,
and glucose. However, given that these factors might act
as intermediate mechanisms on the causal pathway from
depression to hypertension, our models may have been
overadjusted. For example, depressive symptoms were asso-
ciated with body mass index and CRP, both of which have
been implicated in hypertension risk [21, 22]. Indeed, these
mechanisms have also been linked with the association
between depression and coronary heart disease [23–25].
From our results we might speculate that daily stress
partly explains the link between depression and the circadian
BP proﬁle. Participants with severe depressive symptoms
were more likely to report feeling stressed on the ambulatory
BP monitoring day, which corroborates with observations
that depressed individuals are more likely to report events
as stressful and to complain and endorse somatic symptoms.International Journal of Hypertension 5
Heightened BP reactivity to laboratory-induced stressors has
been prospectively associated with a greater risk of hyperten-
sion [26], thus if elicited repeatedly in a person’s life these
responses might be clinically relevant. Moreover, there is also
overlapping biology between the neurohormonal control of
BP and the subsequent downstream eﬀects of psychological
stress, one in particular being the gaseous transmitter and
neuroregulator, nitric oxide [27]. Indeed, naturalistic studies
have shown profound eﬀects of acute stressors on BP. For
example, the World Trade Centre terrorist attacks in New
York on 11th September 2001 produced a substantial and
sustained increase in the BP of participants from the local
community [28]. There was also a 20% increase in systolic
BP following a moderate intensity earth quake that struck
central Italy, which was followed by a long lasting period of
enhanced BP variability and blunted nocturnal BP fall [29].
Work stress has also been associated with elevated 24-hour
ambulatory BP [30] although the ﬁndings from prospective
cohort studies in relation to work stress and hypertension
risk have been generally inconsistent [31–36].
The strengths of this study include the unique sample
of participants from sub-Saharan Africa, a well-validated
measure of depressive symptoms, and the use of 24-hour
ambulatory BP assessments. A limitation is the cross-
sectional design, thus we cannot infer causality, identify
potential mediators, nor determine the direction of the
observed relationship between depression and hypertension.
In addition, we did not assess history of major depression
and recurrent symptoms, which might be important given
the link between persistent depressive symptoms and car-
diovascular risk [37]. In summary, we found an association
between depressive symptoms and 24-hour ambulatory BP
in black and Caucasian Africans. The equivocal nature of the
existing work in this area might be explained by reliance on
clinic BP readings and failure to capture the circadian BP
proﬁle.
Funding
Funding was provided by HART (North-West University)
and National Research Foundation South Africa, Metabolic
Syndrome Institute, France. Dr Hamer is supported by the
British Heart Foundation, UK. The funding organizations
played no role in the design and conduct of the study;
collection, management, analysis, and interpretation of the
data; preparation, review, or approval of the paper.
Author’s Contributions
M. Hamer had full access to the data and takes responsibility
for the integrity of the data and accuracy of the data
analyses. M. Hamer performed statistical analyses. L. Malan
is the principle investigator and led the study. All authors
contributed to the concept and design of study, drafting, and
critical revision of the paper.
Conﬂict of Interests
The authors declare that there is no conﬂict of interest.
Acknowledgments
The authors thank Chrissie Lessing (research nurse) and
Szabolcs P´ eter (MD) for their contribution to data collection
and analysis.
References
[ 1 ]S .B .P a t t e n ,J .V .A .W i l l i a m s ,D .H .L a v o r a t o ,N .R .C .
Campbell, M. Eliasziw, and T. S. Campbell, “Major depression
as a risk factor for high blood pressure: epidemiologic
evidence from a national longitudinal study,” Psychosomatic
Medicine, vol. 71, no. 3, pp. 273–279, 2009.
[ 2 ]B .S .J o n a s ,P .F r a n k s ,a n dD .D .I n g r a m ,“ A r es y m p t o m s
of anxiety and depression risk factors for hypertension?
Longitudinal evidence from the National Health and Nutri-
tion Examination Survey I Epidemiologic Follow-up Study,”
Archives of Family Medicine, vol. 6, no. 1, pp. 43–49, 1997.
[ 3 ] J .H .M a r k o v i t z ,K .A .M a t t h e w s ,W .B .K a n n e l ,J .L .C o b b ,a n d
R. B. D’Agostino, “Psychological predictors of hypertension
in the Framingham study. Is there tension in hypertension?”
Journal of the American Medical Association, vol. 270, no. 20,
pp. 2439–2443, 1993.
[4] D. Carroll, A. C. Phillips, C. R. Gale, and G. D. Batty,
“Generalized anxiety and major depressive disorders, their
comorbidity and hypertension in middle-aged men,” Psycho-
somatic Medicine, vol. 72, no. 1, pp. 16–19, 2010.
[ 5 ]J .A .C .D e l a n e y ,B .E .O d d s o n ,H .K r a m e r ,S .S h e a ,B .M .
Psaty, and R. L. McClelland, “Baseline depressive symptoms
are not associated with clinically important levels of incident
hypertension during two years of follow-up: the multi-ethnic
study of atherosclerosis,” Hypertension, vol. 55, no. 2, pp. 408–
414, 2010.
[ 6 ]L .L .Y a n ,K .L i u ,K .A .M a t t h e w s ,M .L .D a v i g l u s ,T .F .
Ferguson, and C. I. Kiefe, “Psychosocial factors and risk
of hypertension: the Coronary Artery Risk Development in
Young Adults (CARDIA) study,” Journal of the American
Medical Association, vol. 290, no. 16, pp. 2138–2148, 2003.
[ 7 ]M .H a m e r ,G .D .B a t t y ,E .S t a m a t a k i s ,a n dM .K i v i m a k i ,
“Hypertension awareness and psychological distress,” Hyper-
tension, vol. 56, no. 3, pp. 547–550, 2010.
[8] C. M. Licht, E. J. de Geus, A. Seldenrijk et al., “Depression is
associated with decreased blood pressure, but antidepressant
use increases the risk for hypertension,” Hypertension, vol. 53,
no. 4, pp. 631–638, 2009.
[9] B. Hildrum, A. Mykletun, E. Stordal, I. Bjelland, A. A. Dahl,
and J. Holmen, “Association of low blood pressure with
anxiety and depression: the Nord-Trøndelag Health Study,”
Journal of Epidemiology and Community Health, vol. 61, no.
1, pp. 53–58, 2007.
[ 1 0 ]H .N a b i ,J .F .C h a s t a n g ,T .L e f ` evre et al., “Trajectories of
depressive episodes and hypertension over 24 years: the
whitehall II prospective cohort study,” Hypertension, vol. 57,
pp. 710–716, 2011.
[11] A. Scuteri, G. Spalletta, M. Cangelosi et al., “Decreased
nocturnal systolic blood pressure fall in older subjects with
depression,” Aging—Clinical and Experimental Research, vol.
21, no. 4-5, pp. 292–297, 2009.
[12] C. R. Dolder, M. Nelson, and M. Snider, “Agomelatine
treatment of major depressive disorder,” Annals of Pharma-
cotherapy, vol. 42, no. 12, pp. 1822–1831, 2008.
[13] H. W. Koenigsberg, M. H. Teicher, V. Mitropoulou et al.,
“24-hMonitoringofplasmanorepinephrine,MHPG,cortisol,6 International Journal of Hypertension
growth hormone and prolactin in depression,” Journal of
Psychiatric Research, vol. 38, no. 5, pp. 503–511, 2004.
[14] M. Jonas, D. Garﬁnkel, N. Zisapel, M. Laudon, and E.
Grossman, “Impaired nocturnal melatonin secretion in non-
dipperhypertensivepatients,”BloodPressure,v ol.12,no .1,pp .
19–24, 2003.
[15] K. Kroenke, R. L. Spitzer, and J. B. W. Williams, “The PHQ-
9: validity of a brief depression severity measure,” Journal of
General Internal Medicine, vol. 16, no. 9, pp. 606–613, 2001.
[16] P. O. Monahan, E. Shacham, M. Reece et al., “Valid-
ity/reliability of PHQ-9 and PHQ-2 depression scales among
adults living with HIV/AIDS in western Kenya,” Journal of
General Internal Medicine, vol. 24, no. 2, pp. 189–197, 2009.
[17] G. Mancia, G. De Backer, A. Dominiczak et al., “Guidelines
for the management of arterial hypertension: the Task Force
for the Management of Arterial Hypertension of the European
Society of Hypertension (ESH) and of the European Society of
Cardiology (ESC),” Journal of Hypertension,v o l .2 5 ,n o .6 ,p p .
1105–1187, 2007.
[18] P. Verdecchia, G. Schillaci, M. Guerrieri et al., “Circadian
blood pressure changes and left ventricular hypertrophy in
essential hypertension,” Circulation, vol. 81, no. 2, pp. 528–
536, 1990.
[19] C. A. Shively, D. L. Musselman, and S. L. Willard, “Stress,
depression, and coronary artery disease: modeling comor-
bidity in female primates,” Neuroscience and Biobehavioral
Reviews, vol. 33, no. 2, pp. 133–144, 2009.
[20] G. Dwivedi and D. G. Beevers, “Hypertension in ethnic
groups: epidemiological and clinical perspectives,” Expert
Review of Cardiovascular Therapy, vol. 7, no. 8, pp. 955–963,
2009.
[21] K. Rahmouni, M. L. G. Correia, W. G. Haynes, and A. L.
Mark, “Obesity-associated hypertension: new insights into
mechanisms,” Hypertension, vol. 45, no. 1, pp. 9–14, 2005.
[22] P. Mathieu, P. Poirier, P. Pibarot, I. Lemieux, and J. P. Despr´ es,
“Visceralobesity:thelinkamonginﬂammation,hypertension,
and cardiovascular disease,” Hypertension,v o l .5 3 ,n o .4 ,p p .
577–584, 2009.
[23] V. Vaccarino, B. D. Johnson, D. S. Sheps et al., “Depression,
inﬂammation, and incident cardiovascular disease in women
with suspected coronary ischemia: the National Heart, Lung,
and Blood Institute-sponsored WISE study,” Journal of the
American College of Cardiology, vol. 50, no. 21, pp. 2044–2050,
2007.
[24] V. Vaccarino, C. McClure, B. D. Johnson et al., “Depression,
the metabolic syndrome and cardiovascular risk,” Psychoso-
matic Medicine, vol. 70, no. 1, pp. 40–48, 2008.
[25] W. J. Kop, P. K. Stein, R. P. Tracy, J. I. Barzilay, R. Schulz,
and J. S. Gottdiener, “Autonomic nervous system dysfunction
and inﬂammation contribute to the increased cardiovascular
mortality risk associated with depression,” Psychosomatic
Medicine, vol. 72, no. 7, pp. 626–635, 2010.
[26] Y. Chida and A. Steptoe, “Greater cardiovascular responses to
laboratory mental stress are associated with poor subsequent
cardiovascular risk status: a meta-analysis of prospective
evidence,” Hypertension, vol. 55, no. 4, pp. 1026–1032, 2010.
[27] F. Oosthuizen, G. Wegener, and B. H. Harvey, “Nitric oxide
as inﬂammatory mediator in post-traumatic stress disorder
(PTSD): evidence from an animal model,” Journal of Neu-
ropsychiatric Disease and Treatment, vol. 1, pp. 109–123, 2005.
[28] W. Gerin, W. Chaplin, J. E. Schwartz et al., “Sustained blood
pressure increase after an acute stressor: the eﬀects of the 11
September 2001 attack on the New York City World Trade
Center,” Journal of Hypertension, vol. 23, no. 2, pp. 279–284,
2005.
[29] G. Parati, R. Antonicelli, F. Guazzarotti, E. Paciaroni, and
G. Mancia, “Cardiovascular eﬀects of an earthquake: direct
evidence by ambulatory blood pressure monitoring,” Hyper-
tension, vol. 38, no. 5, pp. 1093–1095, 2001.
[30] T. G. M. Vrijkotte, L. J. P. van Doornen, and E. J. C. De Geus,
“Eﬀects of work stress on ambulatory blood pressure, heart
rate, and heart rate variability,” Hypertension,v o l .3 5 ,n o .4 ,
pp. 880–886, 2000.
[31] J. H. Markovitz, K. A. Matthews, M. Whooley, C. E. Lewis,
and K. J. Greenlund, “Increases in job strain are associated
with incident hypertension in the CARDIA Study,” Annals of
Behavioral Medicine, vol. 28, no. 1, pp. 4–9, 2004.
[32] A. Chapman, J. A. Mandryk, M. S. Frommer, B. V. Edye,
and D. A. Ferguson, “Chronic perceived work stress and
blood pressure among Australian government employees,”
Scandinavian Journal of Work, Environment and Health, vol.
16, no. 4, pp. 258–269, 1990.
[33] C. Guimont, C. Brisson, G. R. Dagenais et al., “Eﬀects of
job strain on blood pressure: a prospective study of male
and female white-collar workers,” American Journal of Public
Health, vol. 96, no. 8, pp. 1436–1443, 2006.
[34] P. L. Schnall, J. E. Schwartz, P. A. Landsbergis, K. Warren,
and T. G. Pickering, “A longitudinal study of job strain and
ambulatory blood pressure: results from a three-year follow-
up,” Psychosomatic Medicine, vol. 60, no. 6, pp. 697–706, 1998.
[35] J. P. Fauvel, I. M’Pio, P. Quelin, J. P. Rigaud, M. Laville, and M.
Ducher, “Neither perceived job stress nor individual cardio-
vascular reactivity predict high blood pressure,” Hypertension,
vol. 42, no. 6, pp. 1112–1116, 2003.
[36] B. ¨ Ohlin, G. Berglund, M. Rosvall, and P. M. Nilsson, “Job
strain in men, but not in women, predicts a signiﬁcant rise
in blood pressure after 6.5 years of follow-up,” Journal of
Hypertension, vol. 25, no. 3, pp. 525–531, 2007.
[37] M. Hamer, M. Kivimaki, A. Lahiri, M. G. Marmot, and
A. Steptoe, “Persistent cognitive depressive symptoms are
associated with coronary artery calciﬁcation,” Atherosclerosis,
vol. 210, no. 1, pp. 209–213, 2010.